At OCRA, our mission is to improve the lives of everyone touched by ovarian cancer and, ultimately, find a cure for the disease. And while we have grown and expanded our offerings over the years, we have not wavered from that singular goal. Nor will we.
But science is showing us that in order to solve the mysteries of ovarian cancer, we have to look beyond the ovaries.
Many experts in the field of ovarian cancer treatment and research agree that one of the biggest findings of the past decade has been the discovery that one of the most common (and lethal) forms of ovarian cancer actually originates in the fallopian tubes. This has opened up new opportunities for prevention, and is pointing scientists in what may be promising directions for early detection and screening.
As the world’s leader in the fight against ovarian cancer, we want to support these efforts. We will leave no stone unturned in our pursuit for new understandings, better treatments and ultimately a cure.
Dr. David Chapel and his team are laying new groundwork in better understanding the origins of high grade serous carcinoma, by studying the tissues in the female reproductive tract, particularly the fallopian tubes and endometrium.
Recent research findings show that the surgical removal of fallopian tubes in a procedure known as an opportunistic salpingectomy may prevent the most common subtype of ovarian cancer from developing.
Some ovarian cancers are genetically linked to the gynecologic disorder known as endometriosis, according to recent findings from an international team of researchers.